SUMMARY In a double blind crossover comparison with placebo, the effects of cisapride (10 mg tid for two weeks), a non-antidopaminergic gastrointestinal prokinetic drug, on gastric emptying times and on symptoms were evaluated in 12 patients with chronic idiopathic dyspepsia and gastroparesis. Gastric emptying was studied by a radioisotopic gamma camera technique. The test meal was labelled in the solid component (""'..Tc-sulphur colloid infiltrated chicken liver). Nine symptoms (nausea, belching, regurgitations, vomiting, postprandial drowsiness, early satiety, epigastric pain or burning, heartburn) were graded weekly on a questionnaire. Cisapride was significantly more effective than placebo in shortening the t 1/2 of gastric emptying (p2=)0-4), but no significant difference was observed between the two treatments with regard to the improvement of total symptom score (p2=0 09). No side effects were reported during the study.
Functional disorders of the gastrointestinal tract are common, and represent the most frequent diagnosis in western gastroenterological practice. ' The syndrome of functional dyspepsia is characterised by non-specific postprandial symptoms in the absence of organic disease. Traditional diagnostic tests often fail to reveal any significant abnormality. Consequently, the pathogenesis is still unclear.
Recent studies using more sophisticated techniques, however, suggest possible gastrointestinal motor abnormalities in some patients. Gastrointestinal manometric studies`and myoelectric recordings34 have documented abnormalities in some patients with unexplained dyspeptic symptoms. Delayed gastric emptying of both solidsY and liquids" have been shown in these patients.
The presence of gastrointestinal motor abnormalities and, specifically, of delayed gastric emptying has formed the basis for use of prokinetic drugs in the treatment of dyspeptic syndromes. Metoclo On completion of the emptying study, the stored data were processed by a digital computer (Digital PDP 11/34). A video monitor permitted selection of an area of interest, representing the isotope contained in the stomach. The counts occurring within this area were obtained for each of the 120 frames collected. Decay factors were used to compensate for the decline in radioactivity of "9"Tc.
The gastric emptying curves were plotted as percentage of isotope still present in the stomach against time. These curves were then fitted using a power exponential function' and results were calculated using a BASIC program on a separate computer (M20-Olivetti-Italy) and expressed as tl/2.
The non-linear least-square computer program used to obtain the fitted power exponential curves also provides a measure of goodness of fit, expressed as R' (1-residual sum of squares/total sum of squares).
Gastric emptying was evaluated by this method in 15 healthy volunteers without a history of digestive disorders: 12 men and three women, aged 323+±8X7 years (M+SD) and weighing 66.2+ 10(7 kg. The 95%Oo confidence interval (70-125 min) served to determine the presence of gastric stasis in the dyspeptic patients we examined. Only patients with gastric emptying tl/2 longer than 125 min were included in the present study.
DYSPEPTIC SYMPTOMS SCORING
Each patient was instructed to complete weekly a questionnaire listing nine symptoms: nausea, belching, regurgitations, vomiting, postprandial headache, postprandial drowsiness, early satiety, epigastric pain or burning, heartburn. Each symptom was graded, on a weekly basis: 0=absent; 1= occasionally, slight; 2=moderately often, moderately severe; 3=very often, markedly severe. Two hundred and eighteen healthy volunteers, 130 men and 88 women, aged 41 1±10(3 years (M±SD), had previously completed this questionnaire and served as controls. In this group we obtained weekly scores ranging from 0 to 5, which were considered normal values. A total weekly symptom score greater than 5 was therefore required for entry into the study.
EXPERIMENTAI1 DESIGN
All patients considered eligible for the study on the basis of symptoms were included. All medication was withdrawn and patients entered into a one week drug free run in phase. At the end of this week, gastric emptying was measured. Only patients with delayed gastric emptying were admitted to the trial.
The patients were then randomised and treated with cisapride 10 mg tid orally, 15 t½/2 (basal) -t/2 (drug) x 200 t½/2 (basal) + tl/2 (drug) and compared with the corresponding changes in the total symptom complex (Spearman rank correlation coefficient r5, 2-tailed probability).
IN VITRO STUDIES
To evaluate the stability of 'in vitro' labelled chicken liver, 0-5 g portions of finely diced cooked labelled liver were agitated at 37°C in tubes containing 2 ml filtrated fresh gastric juice. Solid particles and supernatant were separated by centrifugation at 540 g for 15 minutes and then counted by a scintillator well counter (gamma-counter AMSR, Abbott, USA). After a 90 minute incubation, 98±2% (M+SD; nine samples) of radioactivity was still bound to the solid.
An identical technique was used to validate the stability of other radiolabelled solid foods commonly used in gastric emptying studies. When 'in vivo' 9"'Tc The difference between cisapride and placebo in improving the patients' stomach evacuation rate was significant (P2=0-042).
RESPONSE OF SYMPTOMS
The effects of cisapride and placebo on the mean and median values of the weekly scores are shown in Table 2 . Table 3 shows the effects of treatments on the discrete symptoms in both sequence groups. In' comparison with the situation at the start, both cisapride and placebo significantly improved the total symptom scores (P2=0.002; P2=0.012, respectively), but no significant difference (P2=0 09) was detected between the two treatments. Figure 2 , the relative changes in symptom scores correlated significantly with the relative changes in gastric emptying rates (r,=069; p2<0-025).
No such correlation was seen after placebo treatment (r,=0.12; p2=0-72); although symptoms also improved, compared with the pretreatment conditions, gastric emptying rates changed little during placebo treatment.
Discussion
The term dyspepsia includes a wide range of digestive disorders from the mild disturbance experienced by most healthy individuals after eating over large over rich meals to very severe conditions with gross abnormalities of gastrointestinal motility such as in chronic intestinal pseudo-obstruction. To consider dyspeptic patients as a whole may, therefore, be misleading, especially when the effect of a therapy is tested. In the present study, an attempt has been made to 
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